Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Cigna (CI – Research Report) yesterday and set a price target of $350.00. The ...

Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the ...

Each year, Cantor Fitzgerald and BGC donate 100 percent of their global ... Mariano Rivera, Willie Randolph, Dwight Doc Gooden, Olympic gold medallist winners Bode Miller and Mikaela Shiffrin and ...

This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...

Cantor Fitzgerald currently has a “Overweight” rating and a $160.00 price objective on the stock. The consensus estimate for DoorDash’s current full-year earnings is $0.27 per share. Get ...

Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...

Investment firm Cantor Fitzgerald recently penned a research ... Shares were likely range-bound into DOC/BIS announcement, ...

Research analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for shares of Sanara MedTech in a research report issued on Thursday, January 23rd. Cantor Fitzgerald ...